The GIFT Nifty futures, that are an early indicator of the Nifty50 index shares, have been buying and selling increased by 18 factors at 25,526, indicating that the home benchmark indices are prone to make a constructive begin on Friday.
Earlier on Thursday, 3 July, the Home benchmark indices S&P BSE Sensex slumped by 170 factors or 0.20%, and settled at 83,240, whereas the Nifty50 traded 0.19% decrease or 48 factors, closing at 25,405.
Listed here are some shares which can be prone to stay in concentrate on 4 July.
Reliance Industries: RRVL made a strategic minority funding in UK-based FACEGYM—a pioneer in facial health and skincare, underscoring its enlargement into the high-growth magnificence and wellness sector.
Oil and Pure Fuel Company: ONGC signed a Heads of Settlement with Japan’s Mitsui O.S.Okay. Traces below which Mitsui will construct, personal, and function two Very Massive Ethane Carriers (VLECs) for ONGC’s ethane imports. ONGC famous in an change submitting that the deal awaits approval from its Board of Administrators.
Godavari Biorefineries: Godavari Biorefineries secured a European patent for its novel anticancer molecule. The patent, now validated in Spain, the UK, and as a Unitary Patent, covers a extremely potent compound confirmed efficient towards most cancers cells and most cancers stem cells.
Piramal Pharma: Carlyle Group intends to divest as much as 10% of Piramal Pharma by way of block trades, which may elevate about Rs 2,600–2,700 crore. Carlyle’s stake in Piramal stood at 18% as of March 2025.
Emcure Prescribed drugs: BC Investments IV (a Bain Capital fund) plans to promote roughly 2.4% of Emcure Prescribed drugs through block offers value round Rs 551 crore. As of March 2025, BC Investments IV held an 8.68% stake in Emcure.
Aegis Logistics: Aegis Logistics commissioned a brand new liquefied petroleum fuel (LPG) cryogenic terminal at Pipavav, offering 48,000 MT of static storage capability for LPG dealing with and distribution.
Arkade Builders: The corporate has inked a binding settlement to accumulate a whole stake in Filistan for Rs 183 crore, giving the corporate entry to the enduring 4-acre land parcel in Goregaon West, which can be referred to as Filmistan Studios.
Torrent Pharma: The corporate has introduced signing a share buy settlement for buying a further 2.1% stake in JB Chemical compounds and Prescribed drugs Ltd for a complete consideration of Rs 1,600 crore.
The way forward for investing is right here!
Unicorn Indicators leverages superior AI know-how to give you highly effective market predictions and actionable inventory scans. Obtain the app as we speakand 10x your buying and selling & investing journey!
